Navigation Links
Intrepid Investment Bankers LLC Advises Newport Medical Instruments, Inc. in its Sale to Covidien plc

LOS ANGELES, May 1, 2012 /PRNewswire/ -- Intrepid Investment Bankers LLC ("Intrepid"), a leading middle market investment banking firm, today announced the sale of Newport Medical Instruments, Inc. ("Newport") to Covidien plc (NYSE: COV).  The transaction closed on May 1, 2012.  Intrepid acted as the exclusive M&A advisor to Newport in connection with the transaction. 


Newport is a physician-led company, focused solely on the design and manufacture of dependable, life improving ventilators that are affordable for caregivers worldwide. Newport's products are sold in the United States and more than 115 countries worldwide.

Covidien is a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices.  Covidien creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. With 2011 revenue of $11.6 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries.

"This transaction highlights both companies' commitment to driving innovation and growth in the respiratory care sector by expanding their ventilator portfolio and global presence," said Dr. Hong-Lin Du, President of Newport.  "Newport shareholders were very pleased with the strategic guidance and process advice Intrepid has provided."

Mr. Ed Bagdasarian, Managing Director of Intrepid, commented, "We were pleased to have the opportunity to work with the Newport owners and management team to lead the company through the sale process.  After three decades of building the company, its owners decided to entertain strategic discussions with partners that would help accelerate the fulfillment of several exciting growth opportunities.  We were honored to play a part in selecting its future partner and completing a transaction that will help Newport realize its growth opportunities."

The Intrepid team included Ed Bagdasarian, Steve Davis, Adam Abramowitz, Jeremy Lai and Meghan Stenger.

About Intrepid Investment Bankers LLC 

Intrepid Investment Bankers LLC, based in Los Angeles, California, is a mergers and acquisitions and corporate finance advisory firm focused on the middle-market. Intrepid was founded in 2010 by the former principals of Barrington Associates, a firm that grew to become a leading national middle market M&A advisor before its acquisition by Wells Fargo in 2006. Intrepid's services include M&A advisory, equity and debt capital raising and providing strategic advice in complex securities transactions. The firm focuses on the middle market corporate finance needs of entrepreneur and family-owned businesses, private equity sponsors and major corporations. Collectively, the senior team at Intrepid brings over 100 years of mergers and acquisitions advisory experience and has advised on over 250 transactions spanning a broad range of industries, including consumer products and services, industrial manufacturing, healthcare products and services, building products, business services and retail. Member FINRA/SIPC. 

SOURCE Intrepid Investment Bankers LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta
2. IRIDEX to Present at Upcoming Investment Conferences
3. HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
4. Survey of Biomedical Industry CEOs Finds Lack of Investment and Regulatory Environment Threaten Future Growth and Innovation
5. Quanterix Announces Strategic Investment From IQT
6. Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years
7. Healthcare Services No Longer "Restricted" in Chinas Foreign Investment Catalogue
8. AuraSense Therapeutics Secures Series B Equity Investment
9. Cardium and SourceOne Global Partners Enter Into Cross-Strategic Equity Investment with Plans to Jointly Develop Nutritional Supplements and Medical Foods
10. Physicians Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX
11. Physicians Capital Investments Announces Pedro Vergne-Marini, MD Named to Beckers ASC Review "350 People in the ASC Industry to Know"
Post Your Comments:
(Date:10/12/2015)... This study focuses on China,s Genome-Based ... decades, the industry has been growing at a fast pace. ... consumptions in China have transformed ... is one of the world,s major producers for ... world, China is the world,s fastest ...
(Date:10/12/2015)... -- About epilepsy --> ... disorders manifested by benign to severe, disabling, and life-threatening ... malformations and tumors to meningitis, high-risk pregnancies, and trauma ... is unidentified, as is witnessed in the majority of ... between the inhibitory and excitatory signals of the brain, ...
(Date:10/12/2015)... Oct. 12, 2015 A new computer program ... can predict whether they will develop effective language skills ... a study in the journal Brain and Behavior ... In the journal,s Oct. 12 online edition, researchers ... program determines how specific regions of the brain respond ...
Breaking Medicine Technology:
(Date:10/12/2015)... ... 2015 , ... FEI Behavioral Health, a social enterprise with ... management, will present a session at the Wisconsin Society for Human Resource Management ... Chief Operating Officer Daniel Potterton will present an informative workshop, “Training HR to ...
(Date:10/12/2015)... ... October 12, 2015 , ... ... part of a contact channel benchmarking study. Be a part of ... operational strategies for improving customer experience, customer journey, contact channel execution and intelligence, ...
(Date:10/12/2015)... DC (PRWEB) , ... October 12, 2015 , ... ... been selected to receive a Eugene Washington Engagement Award by the Patient-Centered Outcomes ... more effectively with the research community. , The project, entitled “Training Patients ...
(Date:10/12/2015)... ... 12, 2015 , ... The translation for ARIS® 7.x and 9.x to Microsoft ... installations into the Microsoft world. The ARIS models will be fully translated and mapped ... for both IT and Office users it is acknowledged as a competitive alternative to ...
(Date:10/12/2015)... ... October 12, 2015 , ... METTLER TOLEDO is ... processes. In addition, METTLER TOLEDO has collaborated with manufacturing consultant and lean laboratory ... help improve productivity through the identification and elimination of 'hidden' time-wasting activities. Mr ...
Breaking Medicine News(10 mins):